Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Change in Receivables (2023 - 2025)

Historic Change in Receivables for Generation Bio (GBIO) over the last 3 years, with Q3 2025 value amounting to $135000.0.

  • Generation Bio's Change in Receivables fell 8457.14% to $135000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 million, marking a year-over-year decrease of 18232.37%. This contributed to the annual value of $1.2 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Generation Bio's Change in Receivables is $135000.0, which was down 8457.14% from -$1.1 million recorded in Q2 2025.
  • Generation Bio's Change in Receivables' 5-year high stood at $47.5 million during Q1 2023, with a 5-year trough of -$47.5 million in Q2 2023.
  • For the 3-year period, Generation Bio's Change in Receivables averaged around $48875.0, with its median value being $151500.0 (2025).
  • In the last 5 years, Generation Bio's Change in Receivables skyrocketed by 10281.47% in 2024 and then plummeted by 18496.63% in 2025.
  • Over the past 3 years, Generation Bio's Change in Receivables (Quarter) stood at -$47.5 million in 2023, then skyrocketed by 97.92% to -$988000.0 in 2024, then soared by 113.66% to $135000.0 in 2025.
  • Its Change in Receivables stands at $135000.0 for Q3 2025, versus -$1.1 million for Q2 2025 and $168000.0 for Q1 2025.